Estudio de marcadores de superficie celular en pacientes con rinitis alérgica frente a reto con Der p y Der f

Revista Alergia Mexico

Volumn 47, Issue 6, 2000, Pages 190-196

  Ramos, Enrique Rojas ^a   Becerra, Yonathan Garfias ^a   Martínez, Maria Del Carmen Jiménez ^a   Dávila, Bernardo Dávila ^b   Juárez, Luis Terán ^b   Jiménez, Norma Martínez ^d   Vera, Javier Gómez ^c   Solano, Modesto Orea ^c   Galindo, Edgar Zenteno ^d   Ledesma, Ricardo Lascurain ^a  

^a Departamento de Bioquímica

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c ISSSTE

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Allergic rhinitis; Allergic units; Cellular surface molecules; Der p Der f; Nasal challenge

Indexed keywords

ALLERGEN; GLYCOPROTEIN; HOUSE DUST ALLERGEN; MEMBRANE ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; FEMALE; HUMAN; IMMUNOLOGY; MACROPHAGE; MALE; PERENNIAL RHINITIS; T LYMPHOCYTE;

ADULT; ALLERGENS; ANTIGENS, DERMATOPHAGOIDES; ANTIGENS, SURFACE; B-LYMPHOCYTES; FEMALE; GLYCOPROTEINS; HUMANS; MACROPHAGES; MALE; RHINITIS, ALLERGIC, PERENNIAL; T-LYMPHOCYTES;

EID: 8844276787     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Romagnani S. Regulation and deregulation of human IgE synthesis. Immunol Today 1990; 11: 316.
2. Vercelli D, Geha RS. Regulation of IgE synthesis in humans: a tale of two signals. J Allergy Clin Immunol 1991; 88: 285.
3. Del Prete GF, Maggi E, Parrochi P, Chretien I, Tlri A, Macchia D, Ricci M, Banchereau J, de Vries J, Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatansts. J Immunol 1988; 140: 4193.
4. Pene JF, Rouset F, Briere F, Chretien I, Bonnefoy JY, Spits H, Yokota T, Arai N, Arai KI, Banchereau J, de Vries J. IgE Production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons α and γ prostaglandin E2. Proc Natl Acad Sci 1988; 85: 6880.
5. Rojas Ramos E, Martfnez JN. Teoría TH2 en atopia. Revista Alergia México 1999; 46: 83-8
6. June C, Bluestone J, Nadler L, Thompson C. The B7 and CD28 receptor families. Immunol Today 1994; 15: 321-31.
7. Linsley P, Ledbetter J. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191-212.
8. Jirapongsananuruk O, Hofer MF, Trumble AE, Norris DA, Leung DY. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol 1998; 160(9): 4622-7.
9. Larche M, Till SJ, Haselden BM, North J, Barkans J, Corrigan CJ, Kay AB, Robinson DS. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol 1998;161 (11): 6375-82.
10. Bashian G, Braun C, Huang S, Kagey-Sobotka A, Lichtenstein L, Essayan D. Differential Regulation of Human Antigen-specific Th1 and Th2 Responses by the B-7 Homologues, CD80 and CD86. Am J Respir Cell Mol Biol 1997; 17: 235-42.
11. Hershey G, Friedrich M, Esswein L, Thomas M, Chatila T. The association of atopy with a gain-of-function mutation in the alfa subunit uf the interleukin-4 receptor. N Engl J Med 1997; 337: 1720-5.
12. Gavett S, O'Hearn D, Karp C, Patel E, Schofieod B, Finkelman F, Will-Karp M. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Lung Cell Mol Biol 1997; 16: L253-L261.
13. Latza U, Davis S, Wilhelm D, McKnight B, Seyfarth M, Stein H. Soluble cytokine receptor CD30 in atopic disorders: a case control study. Clin Exp Allergy 29: 97-104.
14. Bottari V, Frezzolini A, Ruffelli M, Puddu P, Fontana L, De Pita O. Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention. Allergy 1999; 54: 507-10.
15. Frezzolini A, Paradisi M, Ruffelli M, Cadoni S, De Pita O. Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997;52:106-9.
16. Dummer W, Rose C, Brocker EB. Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis. Arch Dermatol Res 1998; 290: 598-602.
17. Dummer W, Brocker EB, Bastian BC. Elevated serum levels of soluble CD30 on are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis. Br J Dermatol 1997; 137:185-7
18. Leonard C, Tormey V, Faul J, Burke CM, Poulter LW. Allergen-induced CD30 expression on T cells of atopic asthmatics. Clin Exp Allergy 1997; 27: 780-6.
19. Mitra DK, De Rosa SC, Luke A, Balamurugan A, Khaitan BK, Tung J, Mehra NK, Terr AI, O'Garra A, Herzenberg LA, Roederer M. Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. Int Immunol 1999;11(11): 1801-10.
20. Guevara J, Espinosa B, Zenteno E, Vázquez L, Luna J, Perry G, Mena R. Altered Glycosylation pattern of proteins in Alzheimer's Disease. J Neuropath Exp Neurol 1998; 57: 905-14.
21. Lis H, Sharon N. Lectins as molecules and as tools. Ann Rev Biochem 1986; 55: 35-67.
22. Zenteno E, Lascurain R, Montańo LF, Vázquez L, Debray H, Montreuil J. Specifity of Amaranthus leucocarpus lectin. Glycoconj J 1992; 9: 204-8.
23. Chávez R. Aislamiento de una población tipo Th2 por medio de la lectina de Amaranthus leucocarpus. Manuscrite en preparación.
24. Adinoff AD, Rosloniec DM, McCall LL, Nelson HS. Immediate skin reactivity to Food and Drug Administrator-approved standardized extracts. J Allergy Clin Immunol 1990; 86:768-74.
25. De Weck AL, Derer T. Critical Evaluation of the use of skin test and.cellular test in standardization of allergens. Arb Paul Ehrlich Inst Budesamt Sera Impfstoffe Frankf AM 1994; 87: 89-114.
26. Kelso JM. Skin test results in related and unrelated persons with allergic rhinitis. Ann Allergy Asthma Immunol 1996; 77: 43-6.
27. Felnstein AR. Clinical biostatistics. On choosing a mean and other quantitative indexes to describe the location and dispersion of univariate data. Clin Pharmacol Ther 1980; 27: 120-131.